Senior Director, Search & Evaluation Late TA Lead, Immunology

CSL; Waltham (MA); Hybrid; USD 250,000 - 420,000; Full time

Job summary

CSL is expanding its external innovation capability and seeks a Senior Director of Search & Evaluation to shape the Immunology portfolio. You will lead strategic sourcing and evaluation of late-stage external assets, focusing on Phase 2 through marketed drugs.

This role requires deep clinical Immunology expertise, strong KOL engagement, and experience closing deals. Hybrid work onsite 3 days a week at Waltham, MA (and other hubs).

Qualifications

• 15+ years in biopharma with late-stage deal experience.
• Advanced degree (MD/PhD) required.
• Deep Immunology clinical expertise.
• Proven track record in sourcing and closing deals with KOLs.
• Understanding of regulatory pathways and market access.

Responsibilities

• Lead S&E strategy within Therapy Area Leadership Team.
• Lead proactive sourcing for Phase 2 to marketed assets.
• Co-lead NPO evaluation with Early Search Lead.
• Engage with external KOLs and investigators.
• Maintain awareness of standards of care and competition.
• Drive due diligence across clinical, regulatory, commercial, and market access.
• Collaborate with BD and Ecosystem Leads to advance opportunities.
• Represent TA at conferences and cultivate networks.

Skills

Strategic leadership

External collaboration

Clinical development

KOL engagement

Team management

Education

MD/PhD or equivalent

Job description

CSL is expanding its external innovation capability, and we're looking for a Senior Director of Search & Evaluation to help shape the future of our Immunology portfolio.

We are seeking a Senior Director of Search & Evaluation to lead strategic sourcing and evaluation of later-stage external clinical assets in Immunology. This leader will focus on opportunities from Phase 2 through marketed drugs, requiring deep clinical expertise, strong engagement with external Key Opinion Leaders (KOLs) and clinical investigators, and a keen understanding of evolving standards of care. The role is critical to shaping our portfolio through high-impact partnerships and transactions.

To be hybrid-based onsite (3 days a week) at one of our R&D hub sites: Zurich (CH), Maidenhead (UK), Waltham (US), King of Prussia (US). This position cannot be held remotely

Main Responsibilities & Accountabilities

• Serve as the senior S&E leader within the Therapy Area Leadership Team, influencing therapeutic strategy and integrating late-stage external innovation priorities into portfolio planning.
• Lead proactive sourcing efforts for Phase 2 to marketed assets, identifying opportunities that align with TA strategy and unmet medical needs.
• Co-lead internal meetings (with Early Search Lead) focused on evaluating and prioritizing New Product Opportunities (NPOs) within Immunology. NPO meetings are strategic checkpoints where cross-functional teams review potential assets identified by Search and decide whether to advance them for further due diligence and deal negotiations .
• Engage extensively with external KOLs, clinical investigators, and networks to validate asset potential, understand trial designs & clinical endpoints, and anticipate competitive dynamics.
• Maintain deep awareness of changing standards of care and competitive landscapes to inform sourcing priorities and deal strategy.
• Drive cross-functional due diligence for late-stage assets, coordinating clinical, regulatory, commercial, and market access assessments to support governance decisions.
• Partner closely with BD and Regional Ecosystem Leads to advance high-priority opportunities through negotiation and deal close, ensuring seamless handoff and execution
• Represent the TA externally, leading sourcing activities at specialized conferences and building relationships with pharma, biotech, and clinical communities.

Qualifications & Experience Requirements

• 15+ years in biopharma with significant experience in clinical development, external innovation, or business development.
• Advanced degree required (MD, PhD, or equivalent).
• Deep clinical expertise in Immunology
• Proven track record of sourcing and closing late-stage deals and engaging with KOLs and clinical networks.
• Strong understanding of regulatory pathways, market access, and competitive standards of care.